WallStreetZenWallStreetZen

AnalystsJack Allen
Jack Allen's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4204 out of 4241 analysts
Average Return
-27.12%
Win Rate
27%6 out of 22
Risk vs Reward
Poor
Good

Jack Allen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Renovacor IncRCOR
+82.86%$1.75$3.20
2022-09-13 -
2022-11-30
Buy
Carisma Therapeutics IncCARM
+71.35%$3.56$6.10
2023-04-14 -
2023-06-09
Buy
Voyager Therapeutics IncVYGR
+60.68%$3.84$6.17
2021-10-07 -
2022-10-06
Buy
Arcellx IncACLX
+36.96%$29.30$40.13
2023-04-13 -
2023-06-09
Buy
Arcellx IncACLX
+29.41%$31.01$40.13
2023-04-14 -
2023-06-09
Buy

Jack Allen Analyst Color

Get additional color on Jack Allen's coverage of popular stocks

Jack Allen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Arcellx IncACLX
2Buy$39.00-2.82%Initiates Coverage On
2 months ago
Carisma Therapeutics IncCARM
1Buy$10.00+63.93%Initiates Coverage On
2 months ago
Vor Biopharma IncVOR
2Buy$22.00+340.00%Maintains
3 months ago
Crispr Therapeutics AgCRSP
1Hold$46.00-24.89%Initiates Coverage On
3 months ago
Bluebird Bio IncBLUE
1Buy$10.00+173.97%Initiates Coverage On
3 months ago
Intellia Therapeutics IncNTLA
1Hold$42.00-2.87%Maintains
4 months ago
Frequency Therapeutics IncFREQ
2Buy$4.00+952.63%Maintains
4 months ago
Taysha Gene Therapies IncTSHA
3Buy$6.00+597.67%Maintains
4 months ago
Allogene Therapeutics IncALLO
2Buy$12.00+112.77%Upgrades
5 months ago
Instil Bio IncTIL
4Buy$14.00+2,272.88%Maintains
7 months ago
Lineage Cell Therapeutics IncLCTX
1Buy$5.00+262.32%Initiates Coverage On
7 months ago
Renovacor IncRCOR
1Buy$9.00+181.25%Initiates Coverage On
9 months ago
Fate Therapeutics IncFATE
1Hold$28.00N/AInitiates Coverage On
a year ago
Cellectis SaCLLS
2BuyN/AN/AUpgrades
a year ago
Mink Therapeutics IncINKT
1Buy$26.00N/AInitiates Coverage On
2 years ago
Decibel Therapeutics IncDBTX
1Buy$21.00N/AInitiates Coverage On
2 years ago
Voyager Therapeutics IncVYGR
1Buy$9.00N/AUpgrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.